Measurement and Comparison of the Occlusive and Hydrating Capacity of Three Silicone Gels and One Gel Cream
NCT ID: NCT01413789
Last Updated: 2013-04-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
55 participants
INTERVENTIONAL
2011-06-30
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For this study 16 volunteers and ten patients with healed full thickness burns will be included.
After a short period of acclimatization four test areas will be determined. For healthy volunteers the standard zones are located on the inner forearm, two on each forearm.
For patients with healed burns the 4 test zones are located on either the healed donor site or the healed skin grafted area.
In each test zone baseline measurements will be taken before application of the products.After application of the three silicone gels and the hydrating gel cream the trans epidermal water loss (TEWL) and the moisture content of the stratum corneum will be measured by using the TEWAmeter®TM300 and the Corneometer® CM825 (Courage \& Khazaka).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
"A Clinical Study Investigating the Effectiveness of OTC Scar-management Modalities"
NCT04169490
Efficacy and Safety of Aluminaid Versus Hydrogel Wound Dressings
NCT03190655
Evaluation of Antimicrobial Soft Silicone, Silver Containing, Foam Dressing, Mepilex Border Ag, in Second Degree Burns
NCT01418482
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
NCT05618912
Effect of Silicone Gel Versus Contractubex Phonophoresis for Post-burn Hypertrophic Scars
NCT03777891
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients and healthy volunteers
Patients with healed full thickness burns and healthy volunteers will be included in the study
Dermatix
1 application of Dermatix
Kelocote
1 application of Kelocote
BAP scar gel
1 application of BAP scar gel
Alhydran
1 application of Alhydran
Bap Scar Care T
1 application of BAP Scar Care T
Bap Scar Care S
1 Application of Bap Scar Care S
Mepiform
1 application of Mepiform
Scar Ban Elastic
1 application of Scar Ban Elastic
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dermatix
1 application of Dermatix
Kelocote
1 application of Kelocote
BAP scar gel
1 application of BAP scar gel
Alhydran
1 application of Alhydran
Bap Scar Care T
1 application of BAP Scar Care T
Bap Scar Care S
1 Application of Bap Scar Care S
Mepiform
1 application of Mepiform
Scar Ban Elastic
1 application of Scar Ban Elastic
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* not pregnant
* age\>18 years
* male or female
* written authorisation of the patient or volunteer is required.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
S. Monstrey, MD PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Ghent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
Ghent, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011/350
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.